bioRxivDevelopmental BiologyPreprint
Development of a robust automated tool for the annotation of embryo morphokinetic parameters
Magalie FeyeuxiD, Arnaud ReignieriD, M Mocaer, Jenna Lammers, Dimitri MeistermanniD, Sandrine Vandormael‐PourniniD, Michel Cohen‐TannoudjiiD, P. BarrièreiD, Perrine Paul‐GilloteauxiD, Laurent DavidiD, Thomas FréouriD
Abstract
Study QuestionIs it possible to automatically annotate human embryo development in time-lapse devices, with results comparable to manual annotation?\n\nSummary AnswerWe developed an automated tool for the annotation of embryo morphokinetic parameters having a high concordance with expert manual annotation in a large scale-study.\n\nWhat is Known AlreadyMorphokinetic parameters obtained with time-lapse devices are increasingly used for human embryo quality assessment. However, their annotation is timeconsuming and can be operator-dependent, highlighting the need of developing automated approaches.\n\nStudy Design, Size, DurationThis monocentric pilot study was conducted using 701 blastocysts originating from 584 couples undergoing IVF with embryo culture in a time-lapse device and on 4 mouse embryos.\n\nParticipants/Materials, Setting, MethodsAn automated annotation tool was developed based on grey level coefficient of variation and detection of the thickness of the zona pellucida. The timings of cellular events obtained with the automated tool were compared with those obtained manually by 2 expert embryologists. The same procedure was applied on 4 mouse preimplantation embryos obtained with a different device in a different setting.\n\nMain Results and the Role of ChanceAlthough some differences were found when embryos were considered individually, we found an overall excellent concordance between automated and manual annotation of human embryo morphokinetics from fertilization to expanded blastocyst stage (r2=0.94). Moreover, the automated annotation tool gave promising results across species (human, mice).\n\nLimitations, Reasons for CautionThese results should undergo multi-centric external evaluation in order to test the overall performance of the annotation tool.\n\nWider Implications of the FindingsOur system performs significantly better than the ones reported in the literature and on a bigger cohort, paving the way for high-throughput analysis of multicentric morphokinetic databases, providing new insights into the clinical value of morphokinetics as predictor of embryo quality and implantation.\n\nStudy Funding/Competing Interest(s)This study was partly funded by Finox Forward Grant 2016.\n\nTrial Registration NumberNA
- organism: human
- organism: mouse
- assay: imaging
- research focus: cell type annotation
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Robust Automated Assessment of Human Blastocyst Quality using Deep Learning
Pegah Khosravi, Ehsan Mohamad Kazemi, … Iman Hajirasouliha·bioRxiv·Aug 20, 2018
- Harnessing cytoplasmic particles movement of the human early embryo analysed by advanced imaging and artificial intelligence to predict development to blastocyst stage
Giovanni Coticchio, Giulia Fiorentino, … Maurizio Zuccotti·Reproductive BioMedicine OnlinePeer-reviewed·Dec 24, 2020
- Automatic Ploidy Prediction and Quality Assessment of Human Blastocyst Using Time-Lapse Imaging
Suraj Rajendran, Matthew Brendel, … Iman Hajirasouliha·Nature CommunicationsPeer-reviewed·Sep 5, 2024
- Deep learning methods to forecasting human embryo development in time-lapse videos
A. Sharma, A. Dorobantiu, … H. L. Hammer·bioRxiv·Mar 4, 2024
- Label-free 3D subcellular phenotyping of mouse embryos by holotomography enables early prediction of blastocyst formation
Chungha Lee, Geon Kim, … YongKeun Park·bioRxiv·May 7, 2024
- Interaction between gene expression and morphokinetic parameters in undisturbed human embryo culture
Hui Xiao, Adam Stevens, … Daniel R. Brison·bioRxiv·Jun 4, 2024